Breaking News

FDA Gives Go Ahead to Brain Wave Test for Assessing ADHD in Children
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

On Monday, the U.S. Food and Drug Administration (FDA) announced that it has approved the first brain wave test that would help to assess attention-deficit/hyperactivity disorder, commonly known as ADHD, in children and in adolescents 6-17 years of age.

The groundbreaking test is called the Neuropsychiatric EEG-Based Assessment Aid (NEBA) System. It uses electroencephalogram technology to find out the ratio between two standard brain wave frequencies, theta and beta. Particular combinations of these two brain wave frequencies are more prevalent in children and adolescents with ADHD, while such combinations aren’t so prevalent in children without ADHD.


The new brain wave test cleared by the FDA is non-invasive and takes about 15 to 20 minutes to complete. However, the FDA has issued guidance that the test is not to be accepted as a standalone arbiter in the case of ADHD diagnosis, but should be used to confirm an ADHD diagnosis where medical and psychological examinations suggest presence of the disorder.

Christy Foreman, director of the Office of Device Evaluation of the FDA’s Center for Devices and Radiological Health said, “Diagnosing ADHD is a multistep process based on a complete medical and psychiatric exam … The NEBA System along with other clinical information may help health care providers more accurately determine if ADHD is the cause of a behavioral problem.”

ADHD is an extremely common neurobehavioral disorder among children and adolescents, and about 9.5 percent of those between the ages of 4 and 17 were found affected by ADHD according to a 2007 survey of the Centers for Disease Control and Prevention.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!

According to the announcement made by FDA, the NEBA system would go a long way in helping to diagnose ADHD. An independent group of ADHD experts who reviewed the approval process said, “the use of the NEBA System aided clinicians in making a more accurate diagnosis of ADHD when used in conjunction with a clinical assessment.”


Interesting Legal Sites You May Like




Search Now

Mid-level Litigation Associate Attorney


Baltimore office of our client seeks mid-level litigation associate attorney with 3+ years of experi...

Apply Now

Litigation Associate Attorney


Columbia office is seeking a commercial litigation attorney with 2-4 years of experience.

Apply Now

Junior Employment Litigation Attorney

USA-CA-San Francisco

San Francisco office is seeking an attorney with 2-3 years of employment litigation, class action or...

Apply Now

Research and Writing Associate Attorney


Dallas office of our client seeks research and writing associate attorney with 5+ years of experienc...

Apply Now


Staff Attorney


We are seeking 2 part time Staff Attorneys to become a part of our team. The attorneys of the Law Of...

Apply now


USA-KS-Great Bend

The law firm of Watkins Calcara Chartered in Great Bend has an opening for an additional attorney. T...

Apply now

Head of Human Resources and Business Development


SUMMARY OF POSITION:  Under the general supervision of the Director of Administration, the H...

Apply now

Paralegal/Legal Assistant


Must be able to assist the attorneys at the office with a wide variety of tasks, including but not l...

Apply now


To Top